Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term administration of OPC-12759 ophthalmic suspension in dry eye
jRCT2080220651Phase 3
- Sponsor
- Otsuka Holdings
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of rebamipide in dry eye syndrome (DED), sponsored by Otsuka Holdings.
02
Drugs
rebamipide
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on jRCT2080220651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220651.